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TRAF2 Deficiency Results in Hyperactivity
of Certain TNFR1 Signals and Impairment
of CD40-Mediated Responses
molecules to the cytoplasmic regions of the receptors
(Nagata, 1997). One major class of proximal signal trans-
duction molecules is the family of TNFR-associated fac-
tors (TRAFs) (Rothe et al., 1994, 1995; Cheng et al., 1995;
Regnier et al., 1995; Cao et al., 1996; Ishida et al., 1996a,
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Unlike its complex and indirect interaction with
Canada M5G 2M9
TNFR1, TRAF2 can interact directly with other members
of the TNF receptor superfamily that mediate important
immune functions, including CD40, CD30, CD27, 4-1BB,Summary
and RANK (receptor activator of NF-kB) (for review, see
Arch et al., 1998). However, these receptors typicallyTumor necrosis factor (TNF) receptor±associated fac-
recruit additional TRAF proteins also capable of mediat-tor 2 (TRAF2) can interact with various members of
ing intracellular signaling. CD40, for example, can asso-the TNF receptor family. Previously, we reported that
ciate with TRAF2, 3, 5, and 6 (Cheng et al., 1995; RotheTRAF2-deficient mice die prematurely and have ele-
et al., 1995; Sato et al., 1995; Ishida et al., 1996a, 1996b;vated serum TNF levels. In this study, we demonstrate
Tewari and Dixit, 1996). CD40 is expressed on all anti-that TRAF2-deficient macrophages produce increased
gen-presenting cell (APC) types, including B cells, den-amounts of nitric oxide (NO) and TNF in response to
dritic cells, and macrophages. Engagement of CD40TNF stimulation. Furthermore, we could enhance the
with CD40 ligand (CD40L) has been shown to be impor-survival of TRAF2-deficient mice by eliminating either
tant for B and T cell interactions that contribute to B cellTNF or TNFR1. Using these double-knockout mice, we
activation, differentiation, and immunoglobulin isotypeshow that in the absence of TRAF2, the T helper±
class switching (Noelle et al., 1992; Laman et al., 1996).dependent antibody response, CD40-mediated prolif-
Recent data suggest that CD40-CD40L interactions areeration, and NF-kB activation are defective. These
also essential for the association of dendritic cells anddata demonstrate two important roles of TRAF2, one
T cells and thus the initiation of T-dependent immuneas a negative regulator of certain TNFR1 signals and
responses (Noelle, 1996; Grewal and Flavell, 1998). Exthe other as a positive mediator of CD40 signaling.
vivo experiments have shown that TRAF2, TRAF5, and
TRAF6 all have positive effects on CD40-induced activa-Introduction
tion of NF-kB and JNK/SAPK (Rothe et al., 1995; Sato
et al., 1995; Ishida et al., 1996a, 1996b; Lee et al., 1999;Members of the tumor necrosis factor receptor (TNFR)
Tsukamoto et al., 1999). However, the precise contribu-superfamily play important roles in cell death, bone and
tion of each TRAF protein to CD40 signaling in vivofat metabolism, and immune function. Stimulation of a
remains to be resolved.TNFR-related receptor results in receptor aggregation
In this study, we have extended our analysis of TRAF2-and the recruitment of intracellular signal transduction
deficient animals to determine the physiological role
of TRAF2 in the signaling of two receptor complexes,# To whom correspondence should be addressed (e-mail: wen-chen.
yeh@amgen.com). TNFR1 and CD40. First, we investigated whether TRAF2
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Figure 1. TNF Stimulates the Overproduction
of Inflammatory Mediators by TRAF2-Defi-
cient Cells
(A±B) Thioglycollate-elicited peritoneal mac-
rophages were isolated from wild-type and
traf22/2 mice of the C57BL/6 3 BALB/c (F1)
background. Macrophages were incubated
for 24 hr with either mIFNg (50 U/ml) plus
the indicated concentrations of exogenous
mTNF (A) or with the indicated concentrations
of LPS (B). Culture supernatants were as-
sayed for nitrite production. Data shown here
are the representative of two to three mice
per genotype, and at least three independent
experiments were performed. (C) Northern
blot analysis of iNOS and TNF mRNA. Wild-
type and traf22/2 inflammatory peritoneal
macrophages were left untreated or treated
with LPS (5 mg/ml) or mIFNg (50 U/ml) plus
mTNF (10 ng/ml) for 18 hr. RNA blots were
hybridized with 32P-labeled iNOS- and TNF-
specific cDNA probes. Equal loading of RNA
was demonstrated by staining with ethidium
bromide. (D) Unstimulated resident macro-
phages isolated by peritoneal lavage of wild-
type and traf22/2 mice of the C57BL/6 3 CD1
(F3) background were counted and analyzed
by flow cytometry. Equal numbers of Mac-1
and F4/80 double-positive macrophages were plated with mIFNg (50 U/ml) plus the indicated concentrations of exogenous mTNF for 72 hr,
and nitrite production was quantitated. (E) traf22/2 resident peritoneal macrophages were treated with IFNg (50 U/ml) in the absence or
presence of antagonistic antibodies (2 mg each per well) against TNFR1 and TNFR2 for 48 hr, and nitrite production was quantitated. (F) Wild-
type and traf22/2 EF cells were treated with various concentrations of TNF for 18 hr. Culture supernatants were then assayed for nitrite
production as described.
deficiency disrupts the delicate balance of TNFR1 sig- background (C57BL/6 3 BALB/c [Yeh et al., 1997] or
C57BL/6 3 CD1 [data not shown]). We therefore utilizednaling pathways in vivo. We demonstrate that the ab-
sence of TRAF2 causes defective TNF signaling, by the healthier mutant animals of mixed genetic back-
grounds and their littermate controls for these experi-showing that TRAF2-deficient macrophages overpro-
duce TNF and its downstream inflammatory mediator, ments. Surprisingly, thioglycollate-elicited macrophages
isolated from traf22/2 mice of both the C57BL/6 3nitric oxide (NO), specifically in response to TNF stimula-
tion. Furthermore, the elimination of TNF signaling in BALB/c (Figure 1A) and C57BL/6 3 CD1 (data not
shown) genetic backgrounds produced greatly ele-vivo, achieved by generating double-knockout traf22/2
tnf2/2 or traf22/2 tnfr12/2 mice, partially rescues the lethal vated levels of nitrite, the stable end product of nitric
oxide (NO) production, in response to stimulation withphenotype of TRAF2-deficient animals. These double-
knockout mice survive long term, free of many of the TNF plus interferon-g (IFNg). Overproduction of NO by
traf22/2 macrophages was specific to TNF stimulation,abnormalities observed in TRAF2 single-knockout ani-
mals. With respect to the physiological role of TRAF2 as NO levels increased proportionately with the concen-
tration of exogenous TNF, while lipopolysaccharidein CD40 signaling, immunoglobulin isotype switching in
response to virus infection is defective in the absence (LPS) stimulation of activated traf22/2 macrophages re-
sulted in normal or slightly reduced levels of NO produc-of TRAF2, and CD40-mediated proliferation and NF-kB
activation are impaired in mutant cells. Our results define tion (Figure 1B).
Increased NO production in the absence of TRAF2two distinct and apparently opposing physiological
roles for TRAF2: negative regulation of certain signals was confirmed by the levels of inducible NO synthase
(iNOS) mRNA in macrophages 18 hr after treatment withdownstream of TNFR1 and positive regulation of signal-
ing downstream of CD40. TNF plus IFNg. The expression of iNOS mRNA in wild-
type macrophages had returned to the level of that in
unstimulated cells, while it was still strongly elevated inResults
traf22/2 macrophages, consistent with their NO overpro-
duction (Figure 1C). We also measured TNF mRNA 18TRAF2-Deficient Macrophages Overproduce NO
and TNF in Response to TNF Stimulation hr after stimulation of wild-type or traf22/2 macrophages.
In comparison to the wild-type, TNF production in re-TNF plays an important role in the initiation and progres-
sion of inflammatory responses. To investigate the role sponse to TNF stimulation was greatly amplified in the
absence of TRAF2 (Figure 1C).of TRAF2 in TNF-mediated responses, we evaluated the
ability of traf22/2 macrophages to produce inflammatory To rule out the in vivo effect of thioglycollate on
TRAF2-deficient cells, equalized numbers of unstimu-mediators in response to TNF stimulation. The frequency
of viable traf22/2
Role of TRAF2 in TNFR1 and CD40 Signaling
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Figure 2. Elimination of TNF or TNFR1 Res-
cues Growth Defects in Survivor traf22/2 Mice
(A) A representative runted z9-day-old traf22/2
mouse (middle) is shown with two wild-type
littermates (top and bottom). (B) Elimination
of TNF restores growth of traf22/2 mice in a
dose-dependent manner. The adult traf22/2
tnf2/2 mouse (second from the left) is compa-
rable in size to its littermates, while the
traf22/2 tnf1/2 mouse (second from the right) is
runted. (C) Elimination of TNFR1 also restores
growth of traf22/2 mice. traf22/2 tnfr12/2 mice
(left) are comparable in size to their lit-
termates (right).
traf22/2 animals and their littermate controls (C57BL/6 3 2B). To increase the probability of obtaining traf22/2 tnf2/2
double-knockout mice, traf21/2 tnf1/2 females wereCD1) were utilized for experiments. As shown in Figure
1D, naive TRAF2-deficient cells produced increased mated to traf21/2 tnf2/2 males. As shown in Table 1, the
rescue of TRAF2-deficient mice by mutation of TNF wasamounts of NO proportional to TNF stimulation. In con-
trast to elicited macrophages, both wild-type and mutant incomplete since the percentage of survivors was below
that expected by the Mendelian ratio (7.8% versus theresident macrophages produced negligible amounts of
NO in response to LPS alone (data not shown). In addi- expected 12.5%). The partial rescue of TRAF2-deficient
mice from premature lethality by elimination of TNF sug-tion, the significant amount of NO produced by traf22/2
macrophages in response to IFNg alone is likely due to gests that the regulation of TNF levels is critical during
embryogenesis and postnatal survival.a small amount of endogenous TNF secreted by these
mutant cells. As shown in Figure 1E, the combination To further investigate the mechanism of TNF-medi-
ated toxicity in TRAF2-deficient mice, we generatedof antagonist antibodies against TNF receptors blocked
the NO production in cultures treated with IFNg. Indeed, TRAF2/TNFR1 double-knockout animals. Elimination of
TNFR1 in TRAF2-deficient mice significantly enhancedELISA measurements of traf22/2 culture supernatants
treated with IFNg alone revealed levels of 0.2 to 0.5 ng/ the viability of these animals (Table 1). In addition to
increasing viability, complete elimination of either TNFml TNF. Wild-type macrophage cultures also produced
a similar amount of endogenous TNF in the absence of or TNFR1 in TRAF2-deficient mice restored postnatal
growth close to normal levels (Figures 2B and 2C), inany exogenous TNF.
Finally, we examined NO production by TRAF2-defi- sharp contrast to the severe wasting observed in TRAF2-
deficient survivors from the C57BL/6 3 129J back-cient embryonic fibroblasts (EF). As shown in Figure 1F,
traf22/2 EF cells produced high levels of NO in response ground (Figure 2A). The growth of TRAF2/TNF double-
knockout mice was rescued to a slightly greater extentto TNF stimulation, while under our assay conditions
wild-type EF cells showed very little or no NO produc- (90%±95% of wild-type body weight) than that of TRAF2/
TNFR1 double-knockout mice (75%±90% of wild-typetion. Taken together, these results further strengthened
the notion that TRAF2-deficient cells are indeed hyper- body weight). This discrepancy suggests that, in TRAF2-
deficient mice, TNF may be exerting minor cytotoxicresponsive to TNF.
effects through TNFR2 in addition to TNFR1. Interest-
ingly, the survival of TRAF2/TNFR1 double-knockoutTRAF2-Deficient Mice Are Partially Rescued
from Premature Lethality by Deficiency pups was influenced by the maternal genotype for
TNFR1. A tnfr12/2 maternal genotype correlated with afor TNF or TNFR1
The observation that the absence of TRAF2 resulted in higher percentage of surviving traf22/2 tnfr12/2 pups
(closer to the Mendelian ratio) than a tnfr11/2 maternalan increase in the basal serum TNF level and significant
overproduction of TNF by macrophages suggested that genotype (Table 1), suggesting that TNF signaling of
maternal origin might also have an effect on embryonicthe severe phenotype of TRAF2-deficient mice was due
at least in part to TNF-mediated toxicity. This possibility survival. Together, these results indicate that the en-
hanced TNF production in TRAF2-deficient mice re-was examined by the generation of traf22/2 mice that
were also deficient in TNF. When the progeny of parent duces viability and survival and that these effects are
largely mediated through TNFR1.mice that were both compound heterozygotes (traf21/2
tnf1/2) were analyzed, no traf22/2 tnf1/1 progeny survived
at the time of weaning (3 weeks old), a result reproduced
for 10 litters (data not shown). However, a few traf22/2 TNF-Induced NO and IL-12 Production Require TNFR1
and Are Negatively Modulated by TRAF2tnf2/2 pups in these litters were rescued from premature
lethality and survived beyond 3 weeks of age (compare We further examined the role of TRAF2 in macrophage
production of inflammatory mediators using TRAF2/TNFFigures 2A and 2B). In addition, consistent with the gene
dosage effect observed in TNF mutant animals (Marino and TRAF2/TNFR1 double-knockout animals. Elicited
peritoneal macrophages isolated from traf22/2 tnf2/2 ani-et al., 1997), a few traf22/2 tnf1/2 mice in these litters
were also viable. However, the traf22/2 tnf1/2 mice were mals overproduced NO in response to increasing con-
centrations of exogenous murine TNF plus IFNg (Figurenot as healthy as their traf22/2 tnf2/2 littermates, as they
were severely runted and also died prematurely (Figure 3A), recapitulating the phenotype observed in cells from
Immunity
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Table 1. Elimination of TNF or TNFR1 Rescues Viability of traf22/2 Mice
Parents: Male: traf21/2 tnf2/2 x Female: traf21/2 tnf1/2
traf2 genotypes 1/1 1/2 2/2 Total % traf22/2 of Total
tnf genotypes 1/2 11 22 7 103 6.8%
tnf genotypes 2/2 18 37 8 7.8%
Parents: Male: traf21/2 tnfr12/2 x Female: traf21/2 tnfr11/2
traf2 genotypes 1/1 1/2 2/2 Total % traf22/2 of Total
tnfr1 genotypes 1/2 32 63 0 196 0%
tnfr1 genotypes 2/2 36 56 9 4.6%
Parents: Male: traf21/2 tnfr12/2 x Female: traf21/2 tnfr12/2
traf2 genotypes 1/1 1/2 2/2 Total % traf22/2 of Total
tnfr1 genotypes 2/2 13 33 9 55 16.4%
Data are grouped based on maternal TNFR1 genotype. Percentages indicate the proportion of traf22/2 pups from all litters. Only pups that
were viable at the time of weaning (3 weeks old) were enumerated.
TRAF2 single-knockout mice (Figures 1A and 1D). Simi- dosage effect of TRAF2 or hypersensitivity of TNF-defi-
cient cells to exogenous TNF.lar results were observed when unstimulated resident
peritoneal macrophages from traf22/2 tnf2/2 animals
were utilized (data not shown). In contrast, cells from Absence of TNFR1 Rescues Phenotypic Abnormalities
Observed in TRAF2-Deficient Animalsneither traf22/2 tnfr12/2 nor traf21/2 tnfr12/2 animals were
able to produce NO in response to exogenous TNF plus Following the observation that partial rescue of pre-
mature lethality resulted from the elimination of TNFIFNg stimulation (Figure 3B). Consistent with a previous
report (Endres et al., 1997), TNFR1 appears to be the or TNFR1 in TRAF2-deficient mice, we investigated
whether the elimination of TNFR1 rescued other abnor-primary mediator of TNF-induced NO production since
all cells lacking TNFR1 failed to respond to TNF. In addi- malities observed in TRAF2-deficient mice. Thymocytes
from traf22/2 tnfr11/1 mice exhibit exaggerated apo-tion, we measured IL-12 production by elicited macro-
phages and found that this cytokine was also secreted ptosis in response to TNF stimulation (Yeh et al., 1997).
In contrast, both traf22/2 tnfr12/2 and traf21/1 tnfr12/2at increased levels by traf22/2 tnf2/2 cells in response to
TNF treatment. In contrast, IL-12 secretion by traf22/2 thymocytes were resistant to TNF treatment (Figure 4A).
Cells of all genotypes underwent dexamethasone-tnfr12/2 and wild-type elicited macrophages were not
increased by stimulation with TNF (Figure 3C). Macro- induced apoptosis to a similar degree (Figure 4B), dem-
onstrating that the hypersensitivity of TRAF2-deficientphages from traf21/2 tnf2/2 mice produced moderately
elevated levels of NO and IL-12 at high concentrations cells to TNF is specifically mediated through TNFR1. We
previously reported that traf22/2 animals have elevatedof TNF (Figures 3A and 3C), possibly due to a gene
Figure 3. TNF-Induced NO and IL-12 Pro-
duction Requires TNFR1 and Is Negatively
Modulated by TRAF2
(A and B) Peritoneal exudate macrophages
were isolated from traf22/2 tnf2/2 (A) or traf22/2
tnfr12/2 (B) mice as well as appropriate lit-
termate controls. Macrophages were incu-
bated for 24 hr with mIFNg (50 U/ml) plus
the indicated concentrations of mTNF, and
culture supernatants were assayed for nitrite
production. (C) Culture supernatants from the
inflammatory macrophages were assayed for
IL-12p70 by ELISA. Data shown here are rep-
resentative of two to three mice per genotype.
Role of TRAF2 in TNFR1 and CD40 Signaling
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Figure 4. Elimination of TNFR1 Rescues Vari-
ous Phenotypes Associated with TRAF2 Defi-
ciency
(A) Rescue of traf22/2 CD41CD81 (DP) thymo-
cyte hypersensitivity to TNF-induced apo-
ptosis. Thymocytes were plated at 5 3 105
cells per well (24-well plates) and incubated
for 20 hr with medium alone or medium con-
taining the indicated concentrations of mTNF
(A) or dexamethasone (B). Cells were triple-
stained with anti-CD8a, anti-CD4, and 7-AAD.
Viable DP cells (7-AAD-negative) from indi-
vidual treatments were plotted as percent-
ages of the total viable DP cells in the treated
cultures compared to the untreated controls
of the respective genotypes. (C) Absence of
TNFR1 in traf22/2 mice restores normal basal
serum TNF levels. Sera from different animals
of indicated genotypes were taken for analy-
ses. (D) Bone marrow cells harvested from
adult traf21/1 tnfr12/2 (TNFR1-KO control),
traf21/1 tnfr11/2 (WT control), and traf22/2
tnfr12/2 mice were analyzed by flow cytome-
try. The numbers shown in each region repre-
sent the percentage of total cells.
basal serum TNF levels. Analysis of serum TNF levels TRAF2 Deficiency Results in Severely Impaired
VSV-Induced Isotype Switchingin TRAF2/TNFR1 double-knockout mice demonstrated
a complete rescue of this phenotype, with a striking We next investigated the role of TRAF2 in regulating
immunity to pathogens by evaluating the production ofreduction in serum TNF to normal undetectable levels
(Figure 4C). The partial rescue of the lethal phenotype neutralizing antibodies in response to vesicular stomati-
tis virus (VSV) infection. Infection of wild-type mice withof TRAF2-deficient mice by the elimination of TNF or
TNFR1, together with the restoration of normal serum VSV results in T-independent production of virus-spe-
cific IgM, followed by T cell±dependent isotype switch-TNF levels, suggests that TNFR1 signals are involved in
regulating TNF levels, and that TRAF2 plays a negative ing to IgG2a and IgG2b (Oxenius et al., 1996). Double-
knockout mice lacking TRAF2 and either TNFR1 or TNFregulatory role in this pathway.
We previously reported that the absence of TRAF2 were used as the experimental animals for these studies,
since these mutants, unlike TRAF2 single-knockouts,also results in a reduction of B2201 IgM2 CD432 and
B2201 IgM1 B cell precursors in the bone marrow. This are viable. Normal VSV-specific IgM and IgG responses
were mounted in traf21/2 tnf2/2 mice. In contrast, traf22/2depletion could either be due to impaired early B cell
development or could occur as a secondary effect of tnf2/2 mice mounted normal IgM responses but had se-
verely impaired IgG responses (about 64-fold lower)TNF toxicity. Elimination of TNFR1 in TRAF2-deficient
mice restored the number of B cell precursors to normal (Figure 5A). Similar results were obtained when traf22/2
tnfr12/2 mice were compared to traf21/2 tnfr12/2 micelevels (Figure 4D). This suggests that the decrease in B
cell precursors observed in traf22/2 animals is most likely (Figure 5B). Immunoglobulin (Ig) isotype switching has
been shown to depend on collaboration between typea secondary effect of TNF toxicity. Collectively, these
results demonstrate that abrogation of TNFR1 signaling 1 T helper cells and B cells (Zinkernagel et al., 1990).
Defective isotype switching observed in the absence ofprevents the appearance of phenotypes seen in TRAF2-
deficient mice. TRAF2 therefore implicates this protein in the positive
Immunity
384
Figure 6. TRAF2 Is Required for CD40-Induced Proliferation and
NF-kB Activation in Splenocytes
(A) Splenocytes were plated at 1 3 105 cells/well and left untreated
or treated with anti-CD40 mAb (10 mg/ml) or LPS (10 mg/ml) for 2
days. Plates were then pulsed with [3H]-thymidine for 14 hr. Each
bar represents the mean of quadruplicate samples. (B) Gel mobility
Figure 5. TRAF2 Is Required for Virus-Induced Neutralizing Anti- shift assays were performed on splenocytes that were left untreated
body Responses or treated with anti-CD40 mAb (10 mg/ml) for the indicated time-
(A and B) Mice were immunized with 2 3 105 PFU VSV-IND intrave- points. Nuclear extracts were prepared as described in the Experi-
nously. Sera were collected after 4 and 8 days and assayed for mental Procedures, incubated with an oligonucleotide probe spe-
neutralizing IgM and IgG titers as described in Experimental Proce- cific for NF-kB, fractionated on a 5% polyacrylamide gel, and
dures. Each bar represents the mean of the sera from two mice. visualized by autoradiography. The position of activated NF-kB is
The experiment in (A) using TRAF2/TNF double-knockout mice was indicated.
done once. The experiment in (B) using TRAF2/TNFR1 double-
knockout mice was repeated twice.
these double-knockout mutant cells proliferated nor-
mally upon LPS stimulation. Furthermore, the prolifera-regulation of signaling events that are important in either
tion of traf22/2 tnfr12/2 splenocytes in response to vari-the activation of T helper cells and/or in the collaboration
ous T cell stimuli was normal (data not shown).between T and B cells.
A critical event downstream of CD40 cross-linking
is the activation of the transcription factor NF-kB. WeAbsence of CD40-Induced Proliferation and NF-kB
examined the ability of traf22/2 tnfr12/2 splenocytes toActivation in TRAF2-Deficient Splenocytes
activate NF-kB in response to CD40 stimulation usingThe failure to mount significant IgG responses to VSV
a gel mobility shift assay. Elimination of TRAF2 resultedinfection has also been demonstrated in CD40L knock-
in complete abrogation of NF-kB activation in responseout mice (Oxenius et al., 1996). Recent biochemical stud-
to CD40 cross-linking (Figure 6B). These data provideies have shown that CD40 cross-linking recruits TRAF2,
physiological evidence that TRAF2 is essential for trans-3, and 5 directly to the C-terminal cytoplasmic domain of
ducing a positive signal triggered by CD40 ligation.CD40 and TRAF6 to its N-terminal cytoplasmic domain
(Pullen et al., 1998; Lee et al., 1999; Tsukamoto et al.,
1999). To distinguish the function of TRAF2 from the Discussion
roles played by other TRAF proteins in the CD40 signal-
ing pathway, we investigated the responses of TRAF2- Biochemical studies have linked TRAF2 to the signaling
complexes of many TNF receptor family members.deficient cells to CD40 cross-linking in vitro. Total spleno-
cytes were isolated and evaluated for their responses These receptors include TNFR1, where a complex
signaling path involves interactions between TRADD,to CD40 cross-linking and LPS, agents known to stimu-
late B cells. In contrast to cells from traf21/1 tnfr11/2 or TRAF2, and receptor interacting protein (RIP). In addi-
tion, TRAF2, among other TRAFs, can bind directly totraf21/1 tnfr12/2 mice, the B cell proliferative response
induced by CD40 cross-linking was completely abro- CD40. From studies utilizing in vitro or overexpression
systems, TRAF2 has been reported to play a positive rolegated in traf22/2 tnfr12/2 splenocytes (Figure 6A). This
defect was specific for CD40-induced proliferation, as in mediating signaling from both receptors. Specifically,
Role of TRAF2 in TNFR1 and CD40 Signaling
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TRAF2 was implicated as the principal transducer of of the many molecules downstream of TRAF2 that serve
receptor-mediated signals leading to the activation of to execute its effects.
NF-kB and stress-activated kinases (JNK/SAPK) (Liu et
al., 1996). In this report, we provide in vivo evidence that
Regulation of the Production of InflammatoryTRAF2 is indeed required for CD40 signaling. However,
Mediators by TRAF2the loss of TRAF2 results in not decreased but excessive
Macrophages produce various inflammatory cytokinesTNF signaling mediated primarily through TNFR1. This
and downstream mediators in response to activation bysharp contrast illustrates not only the disparate nature
a number of stimuli. Many of these stimuli, includingof CD40 and TNFR1 signaling but also suggests a novel
TNF and LPS, trigger signaling events resulting in themolecular mechanism of how TRAF2 might modulate
activation of the transcription factor NF-kB, which isTNF responses.
required to transactivate the expression of many proin-Several mechanisms have been proposed for main-
flammatory cytokine genes as well as iNOS (Nussler andtaining a physiological equilibrium of TNF signals in vivo.
Billiar, 1993; Baeuerle and Henkel, 1994). In this report,First, the action of TNF may be regulated by stimuli-
we show that TRAF2-deficient macrophages producetriggered metalloprotease-dependent cleavage of mem-
increased amounts of nitric oxide and TNF specificallybrane-bound TNF receptors. This cleavage not only
in response to exogenous TNF treatment (Figures 1A,clears TNF receptors from the membrane but also gener-
1C, and 1D). Such increases seem to occur at the mRNAates a pool of soluble receptors that competitively bind
level, possibly due to either enhanced inos and tnf geneto and sequester the ligand (TNF). Failure of this receptor
transcription or a reduced rate of mRNA degradation inshedding would result in a reduced amount of soluble
cells lacking TRAF2. Since TNF-induced NF-kB activityTNF receptors in the circulation and the retention of
was previously found to be normal or only slightly de-functional receptors on the cell membrane. Recently, it
creased in TRAF2-deficient cells (Yeh et al., 1997), it iswas reported that mutations in the TNFR1 extracellular
likely that an as yet undefined TRAF2-dependent butdomain that impair receptor shedding are linked to in-
NF-kB-independent pathway is responsible for the TNF-herited autoinflammatory syndromes in humans (Mc-
induced increase in inflammatory mediator production.Dermott et al., 1999). While this phenomenon presents
Our results also show that the dysregulated produc-a novel mechanism for dysregulated TNF signaling, it is
tion of NO and TNF in traf22/2 macrophages is specifi-unlikely that TRAF2 deficiency results in impaired TNF
cally dependent on stimulation by TNF. While endoge-receptor shedding. Indeed, levels of soluble TNFR1 and
nous TNF plays a role in increased NO production byTNFR2 in sera of TRAF2-deficient animals are not re-
traf22/2 macrophages (Figures 1A, 1D, and 1E), traf22/2duced compared to wild-type animals (L. N. and W. C. Y.,
tnf2/2 macrophages also exhibit a hyperactivity in re-unpublished data).
sponse to exogenous TNF (Figure 3A). Moreover, elimi-A second mechanism to downregulate TNF signaling
nation of TNFR1 in macrophages completely abrogatedinvolves the intracellular protein SODD (silencer of death
their proinflammatory responses to TNF and IFNg (Fig-domains), which can bind to the cytoplasmic domain
ure 3B). In addition, we have demonstrated that TRAF2of TNFR1 and prevent the recruitment of TRADD and
plays a negative regulatory role in TNF-induced NO pro-consequently other signaling proteins (Jiang et al.,
duction not only in macrophages but also in another1999). In this scenario, SODD could inhibit ligand-inde-
cell type such as embryonic fibroblasts (Figure 1F). Stim-pendent self-association of TNFR1 molecules in resting
ulation of TRAF2-deficient macrophages with LPS ap-cells and could also participate in quenching TNFR1
peared to result in reduced NO production comparedsignaling shortly after receptor stimulation. It remains
unclear how the absence of TRAF2 might alter the inter- to wild-type cells (Figure 1B), suggesting that optimal
action between SODD and TNFR1 and thus the TNFR1 LPS signaling in macrophages requires TRAF2. How-
signaling complex. ever, we also observed that TRAF2-deficient spleno-
A third proposed mechanism postulates that stimula- cytes proliferated normally in response to LPS stimula-
tion by TNF can induce a negative feedback loop in a tion. Further experiments are required to address the
cell such that it downregulates endogenous TNF synthe- possibility of a tissue-specific dependence on TRAF2
sis. It was recently discovered that TNF treatment in- in LPS signaling.
duces the expression of tristetraprolin (TTP), a molecule
that can bind to AU-rich elements (ARE) in the 39-untrans-
The Role of TRAF2 in TNFR1 Signalinglated region of TNF mRNA and induce its destabilization
We have discussed above experimental results that re-(Carballo et al., 1998). Such a negative feedback loop
veal an unconventional role for TRAF2 as a negativebecomes very complicated, once one considers the
regulator of TNFR1 signaling. However, TRAF2 maynumber of components that could potentially be regu-
carry out this negative regulatory function by servinglated. These would include elements in the signal trans-
as a positive mediator in TNF-induced pathways thatduction cascades for both TNF receptors, the transcrip-
antagonize the proapoptotic and other detrimental ef-tion factor complex that binds to regulatory elements
fects of TNFR1 signaling. As mentioned above, stimula-of the tnf gene, and the protein complex (including TTP)
tion of TNFR1 can simultaneously activate pathwaysthat affects the stability of TNF mRNA. The potential
leading to apoptosis and antiapoptosis. Proximal signal-involvement of TRAF2 in a feedback loop controlling
ing of TNF-mediated apoptosis involves the interactionTNF synthesis is an intriguing possibility, particularly
of TRADD and FADD, while the cytoprotective pathwaysince TRAF2 deficiency results in increased levels of
depends on a complex composed of TRADD, RIP, andTNF mRNA and circulating TNF. Further support for this
model will require the identification and characterization TRAF2. In the absence of TRAF2, TNF signaling through
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TNFR1 may be dominated by the TRADD-FADD interac- utilizes multiple TRAF proteins for signaling. While the
exact mechanism of signaling is unclear, CD40 appar-tion, which leads to apoptosis. This suggests that there
exists an important balance of TNF signaling in normal ently recruits TRAF2, 3, and 5 to the C-terminal cyto-
plasmic tail of the receptor and TRAF6 to an N-terminalcells and that TRAF2 may be essential for mediating a
signaling pathway that antagonizes TNF-induced apo- domain of the cytoplasmic tail. From biochemical and
protein overexpression studies, both parts of the CD40ptosis. NF-kB activation has been implicated as a key
event in mediating cell survival. However, we have shown cytoplasmic region as well as TRAF2, TRAF5, and
TRAF6 are thought to mediate CD40-induced NF-kBthat TRAF2 plays only a minor role in TNF-induced
NF-kB activation (Yeh et al., 1997). More relevant may activation. Using human CD40 constructs with muta-
tions at specific sites in the cytoplasmic domains, twobe the observation (also reported by others) that TRAF2
is specifically required for TNF-induced SAPK/JNK acti- distinct pathways of CD40 signaling have been demon-
strated: one dependent on TRAF2 or TRAF5 and thevation (Lee et al., 1997; Yeh et al., 1997). TRAF2 can
also interact with cIAP (cellular inhibitor of apoptosis other dependent on TRAF6 (Tsukamoto et al., 1999).
A report by Lee et al. (1999) implicated TRAF2 in theprotein) family proteins, which have been recently pro-
posed to bind directly to and inhibit terminal caspases upregulation of intercellular adhesion molecule-1 (ICAM-1)
induced by CD40 engagement. However, conflicting evi-(Deveraux et al., 1997, 1998; Roy et al., 1997). Thus,
there are several mediators downstream of TRAF2 with dence was reported by Lee et al. (1997), who used a
transgenic mouse strain expressing a dominant-nega-the potential to contribute to TNF-induced, NF-kB-inde-
pendent cytoprotection. tive mutation of the TRAF2 protein to show increased
proliferation of B cells and upregulation of ICAM-1, B7-1,It is also clear that TRAF2 can mediate pathways that
play regulatory roles in nonapoptotic responses induced and CD23 in response to induction by CD40.
Using cells isolated from TRAF2-deficient mice, wevia TNF and TNFR1. TRAF2-deficient mice exhibit a
cachexia-like phenotype possibly caused by elevated have demonstrated unequivocally and physiologically
that TRAF2 is required for CD40-induced proliferationserum TNF levels. Strikingly, elimination of TNF or
TNFR1 signaling in traf22/2 mice was able to rescue and NF-kB activation. This result is further bolstered
by our recent observation in TRAF6-deficient mice thatmany of them from premature lethality. It has been dem-
onstrated that TNF can exert an anabolic effect through CD40 also requires TRAF6 for signaling (Lomaga et al.,
1999). Gene-targeted disruption of TRAF6 completelyinhibition of insulin signaling and adipocyte develop-
ment (Hotamisligil et al., 1994, 1996; Argiles et al., 1997). abolished CD40-mediated NF-kB activation. Taken to-
gether, these data suggest that TRAF2 and TRAF6 areHowever, a detailed molecular mechanism connecting
the TNF signal transduction machinery to the insulin both essential for CD40 signaling. It is possible that
TRAF2 and TRAF6 reside in two separate pathways,signaling cascade remains to be elucidated. It is possi-
ble that TRAF2 mediates signals keeping the cachectic neither of which is sufficient on its own to mediate CD40
signaling. Alternatively, TRAF2 might interact weaklyas well as the proapoptotic effects of TNF in check, so
that wild-type animals and cells are able to avoid TNF with TRAF6 via the TRAF domains, as has been pre-
viously suggested from studies using a yeast two-hybridtoxicity.
The rescue of traf22/2 animal viability by deletion of system (Cao et al., 1996). Intermolecular signals could
conceivably be coordinated using the TRAF ring fingerTNF or TNFR1 was not complete. A number of traf22/2
tnf2/2 and traf22/2 tnfr12/2 animals died at the embryonic domains. Such a scheme might help reconcile the dis-
crepancy between our results and those obtained fromstage. In contrast, almost all double-knockout mice that
survived embryogenesis achieved long-term survival the study of the TRAF2-dominant-negative transgenic
animals. It is possible that, in the complete absence of(6±9 months). This finding suggests that signaling by
molecules related to TNF or via receptors that can re- any form of TRAF2 (as in the TRAF2 knockout mouse),
the proposed TRAF2-TRAF6 complex required for CD40place TNFR1 may play a role in regulating embryonic
survival in the absence of TRAF2. Lymphotoxin-a (LTa) signal transduction simply cannot assemble. However,
in the dominant-negative TRAF2 transgenic animal,is a cytokine that can bind to TNFR1 (Ruddle, 1992),
while TNFR2 is the alternate receptor for TNF in traf22/2 wild-type TRAF2, TRAF6, and a mutant TRAF2 protein
containing only the TRAF domain would all be present.tnfr12/2 animals. Determination of the effects of these
molecules on embryonic survival awaits the generation A CD40 signaling complex could still assemble and,
of triple-knockout mouse strains. Other candidates in- in fact, the TRAF2-TRAF6 interaction could be much
clude death receptors such as death receptors 3 and 6 stronger than in wild-type cells due to locally increased
(DR3 and DR6), which, like TNFR1, utilize TRADD to concentrations of the TRAF domain. Such a scenario
initiate their signaling cascades (Ashkenazi and Dixit, could account for an increased CD40-induced response
1998; Pan et al., 1998). It is possible that some of the in the presence of dominant-negative TRAF2 mutant
phenotypes of TRAF2-deficient mice result from disrup- molecules but a decreased response to CD40 in the
tions of signaling mediated by these other receptors. complete absence of TRAF2.
The phenotypes of the double-knockout mice empha- Our results also showed that TRAF2 has a role in the
size the potential complexity of the signaling web sur- T-dependent B cell response, specifically in Ig-isotype
rounding TRAF2. switching. TRAF2-deficient animals fail to mount IgG
responses to VSV infection (even at time points up to
18 days after infection; data not shown), and CD40 sig-The Role of TRAF2 in CD40 Signaling
naling was impaired in splenocytes in the absence ofCD40 belongs to the subset of TNF receptor superfamily
members that does not contain a death domain and TRAF2. These data are consistent with the phenotype
Role of TRAF2 in TNFR1 and CD40 Signaling
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Measurement of Serum TNFof CD40L-deficient mice that mount normal T-indepen-
Whole blood was centrifuged in a Microtainer serum separator (Bec-dent B cell responses to VSV but are defective in Ig-
ton Dickinson) and the sera were stored at 2708C. Assay of serumisotype switching (Oxenius et al., 1996). If in fact the
TNF was performed in duplicate on serum samples diluted 1:2 or
defect in Ig-isotype switching observed in TRAF2-defi- 1:4 using the mTNFa ELISA kit (Genzyme) according to the manufac-
cient animals is due to an impairment of CD40 signaling, turer's instructions.
it implies that TRAF2 is involved in the activation of APC
VSV Infection and Neutralization Assayfunction (which in turn is required for activation of T
Vesicular stomatitis virus, serotype Indiana (VSV-IND; Mudd-Sum-helper cells) and/or plays a direct role in Th-B collabora-
mers isolate), originally obtained from Lud Prevec (McMaster Univer-tion. Further studies are required to address the precise
sity, Hamilton, Canada), was grown on BHK-21 cells (CRL 8544;
role of TRAF2 in the T-dependent B cell response. Pres- ATCC) infected at low multiplicity and plaqued on Vero cells
ently, we cannot rule out the involvement of other recep- (McCaren et al., 1959). For immunization of mice with VSV-IND, 2 3
tors utilizing TRAF2 signaling that might also contribute 105 PFU of live virus was injected i.v. in 200 ml of Balanced Salt
Solution. Neutralizing titers of sera were determined as describedto Ig-isotype switching. One such candidate is RANK,
(Roost et al., 1990). In brief, sera were prediluted 40-fold in MEMsignaling through which has been implicated in dendritic
supplemented with 2% FCS and then heat-inactivated for 30 mincell and activated T cell functions in addition to the
at 568C. Serial 2-fold dilutions of heat-inactivated sera were mixed
differentiation and activation of osteoclasts (Anderson with equal volumes of VSV preparations containing 500 PFU/ml.
et al., 1997; Hsu et al., 1999; Kong et al., 1999). Further The mixture was incubated for 90 min at 378C in an atmosphere
examination of the RANK signaling pathway in TRAF2- containing 5% CO2. One hundred microliters of the serum-virus
mixture was transferred onto Vero cell monolayers in 96-well plates,deficient animals will be required to clarify its involve-
incubated for 60 min at 378C, and then overlaid with 100 ml DMEMment in the T-dependent B cell response.
containing 1% methylcellulose. After incubation overnight at 378C,
the overlay was removed and the monolayer was fixed and stained
Experimental Procedures with 0.5% crystal violet. The highest dilution of serum that reduced
the number of plaques by 50% was taken as the neutralizing titer.
Animal Husbandry and Generation of traf22/2 tnf2/2 and traf22/2 To determine IgG titers, undiluted serum was pretreated with an
tnfr12/2 Mice equal volume of 0.1 M 2-mercaptoethanol in saline as described
Mice were housed in a specific-pathogen-free facility according to (Scott and Gershon, 1970). Titers represent log2 steps of 40-fold
the ethical and institutional guidelines of the Ontario Cancer Insti- prediluted sera.
tute. traf22/2 mice (Yeh et al., 1997) that had been backcrossed
into the C57BL/6J background for at least four generations were Cellular Proliferation Assays
crossbred to tnf2/2 (Marino et al., 1997) or tnfr12/2 (Pfeffer et al., 1 3 105 viable nucleated splenocytes per well (96-well plates) were
1993) mice of similar genetic backgrounds. Genotypic analyses of cultured in quadruplicate in Iscove's medium supplemented with
the animals were performed as previously described (Pfeffer et al., 10% heat-inactivated fetal bovine serum (Sigma). Cells were un-
1993; Marino et al., 1997; Yeh et al., 1997). treated or treated with either rat IgG2a anti-mouse CD40 mAb (Phar-
Mingen, 3/23, 10 mg/ml) or LPS (Difco, 10 mg/ml) for 2 days. Plates
Nitric Oxide Production in Macrophage and Embryonic were pulsed with 1 mCi [3H]-thymidine per well for 14 hr and har-
Fibroblast Cultures vested onto glass fiber filters. [3H]-thymidine uptake was measured
Elicited peritoneal macrophages (PEC Mé) were obtained from peri- using a scintillation counter (Topcount, Canberra Packard).
toneal lavage of mice injected 5 days previously with 1.5 ml of 4%
thioglycollate broth (Difco). Macrophages (2 3 105) were incubated Gel Mobility Shift Assay
with 1, 10, 100, or 1000 ng/ml LPS (Sigma) or 0.1, 1, 10, or 100 ng/ Splenocytes (2 3 107), either untreated or stimulated with anti-mouse
ml recombinant mTNFa plus 50 U/ml recombinant mIFNg (R & D CD40 mAb (10 mg/ml) for various times, were harvested for nuclear
Systems) for 18 hr in 96-well flat-bottomed microtiter plates. In extracts that were then subjected to gel mobility shift assay for NF-
experiments where unstimulated, resident macrophages were used, kB activity according to protocols previously described (Yeh et al.,
cells from peritoneal lavage were counted and analyzed by flow 1997).
cytometry. Equal numbers (2.5 3 104) of Mac-1 (PharMingen) and
F4/80 (Caltag) double-positive macrophages were plated for treat- Acknowledgments
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